製品名:1-(4-bromo-2-methoxy-6-methyl-phenyl)-3-(2-trimethylsilylethoxymethyl)hexahydropyrimidine-2,4-dione

IUPAC Name:1-(4-bromo-2-methoxy-6-methylphenyl)-3-{[2-(trimethylsilyl)ethoxy]methyl}-1,3-diazinane-2,4-dione

CAS番号:2940958-65-4
分子式:C18H27BrN2O4Si
純度:95%
カタログ番号:CM1076998
分子量:443.41

包装単位 有効在庫 価格(USD) 数量
CM1076998-100mg in stock ŴǧǕ
CM1076998-250mg in stock ɅƻǕ
CM1076998-500mg in stock ƻǕƱ
CM1076998-1g in stock ƀƀǕƙ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2940958-65-4
分子式:C18H27BrN2O4Si
融点:-
SMILESコード:COC1=CC(Br)=CC(C)=C1N1CCC(=O)N(COCC[Si](C)(C)C)C1=O
密度:
カタログ番号:CM1076998
分子量:443.41
沸点:
MDL番号:
保管方法:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.